Comparative Effectiveness of COPD Treatments

NCT03376295 · clinicaltrials.gov ↗

COMPLETED

Status

3954

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: LABA and the LAMA tiotropium (LABA-TIO)
DRUG: LABA and an ICS (LABA-ICS)

Sponsor

Boehringer Ingelheim